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ABSTRACT 
The burden of cardiovascular disease is rising in American Indians.  Compared to other 
racial and ethnic groups, American Indians have greater risk factors, prevalence, and mortality 
rates for cardiovascular disease compared to other races (Eschiti, 2005), including diabetes 
mellitus, obesity, hypertension, and tobacco use (Kurian & Cardarelli, 2007).  With respect to 
American Indians undergoing surgical revascularization with coronary artery bypass grafting, 
mortality rates are reported to be higher than the general population and other ethnic groups 
(Nallamothu et al., 2001).  The present project evaluates current algorithm driven protocols in 
relation to discharge medications and adherence to follow-up care in this at-risk population.    
 While the need for patient education is vital to the overall reduction of mortality related 
to coronary artery disease in all populations, we must first ensure health care providers are 
providing care using evidenced-based practice guideline.  With the American College of 
Cardiology Foundation and American Heart Association evidenced-based guideline, there should 
be an improvement in medical therapy and follow-up care, which will ultimately affect the 
median and long-term patient outcomes.  
 A retrospective chart review of patients undergoing surgical coronary revascularization at 
Sanford Health Fargo, North Dakota from 2008 to 2013 was performed.  Of the 204 patients 
identified, 100 were American Indian.  A 1:1 comparison with individuals of non-American 
Indian decent was completed.  Medications on discharge and follow-up medical appointments 
were evaluated and mortality within one year was assessed.  
The Americans Indians patients were younger (61.3 vs 64.1 years; p<0.0306); had 
significantly higher rates of diabetes mellitus and insulin-dependent diabetes mellitus, and were 
significantly more likely to be active tobacco smokers.  American Indians were less likely to be 
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discharged on a beta-blocker (90.0% vs 97.12%; p=<0.0375).  Postoperative medical follow-up 
in the American Indian patients had statistically significant deficiencies when compared to non-
American Indians follow-up care with a primary care provider.  Overall, the results of this 
project suggest a greater need for health care providers to adhere to American College of 
Cardiology Foundation and American Heart Association guideline directed medical therapy 
following coronary artery bypass graft surgery and improvements in outpatient medical care 
including follow-up. 
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CHAPTER ONE. INTRODUCTION 
The burden of cardiovascular disease (CVD) continues to rise in American Indians (AIs) 
(Welty et al., 2002).  According to the Centers for Disease Control and Prevention (CDC, 2011), 
among racial/ethnic populations, coronary artery disease (CAD) prevalence was greatest among 
AI at 11.6%.  Additionally, AIs have greater risk factors, and mortality rates for cardiovascular 
disease (CVD) compared to other races (Eschiti, 2005; Veazie et al., 2014).  Risk factors include 
comorbidities such as, diabetes mellitus, obesity, hypertension, and smoking (Kurian & 
Cardarelli, 2007; Roger et al., 2012).  These increased risk factors, not surprisingly, result in 
twice the numbers of cardiovascular events as compared to the non- AI population, in turn 
leading to higher mortality rates in this population.   
With respect to AIs undergoing surgical revascularization with coronary artery bypass 
grafting (CABG), mortality rates are reported to be four-fold greater than the general population 
and other ethnic groups (Nallamothu et al., 2001).  This disparity may be linked to several 
factors, including geographical location, a shortage of health care resources, low volume surgical 
centers, and reduced access to care (Becker & Rahimi, 2006; Bridges, Edwards, Peterson, & 
Coombs, 2000; Espey et al., 2014; Nallamothu et al., 2001).  Health care disparities in AIs 
undergoing surgical coronary revascularization are undoubtedly problematic.  The goal of this 
project is to improve intermediate and long term patient outcomes for AIs following coronary 
artery bypass graft (CABG) surgery through the adherence to American College of Cardiology 
Foundation/American Heart Association (ACCF/AHA)  evidenced-based guideline for directed 
medical therapy, follow-up care after surgery and the development of a CABG Patient Discharge 
Algorithm.    
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Background and Significance  
Increased risk factors result in twice the numbers of cardiovascular events for AI as 
compared to the non- AI population, in turn leading to higher mortality rates in this population 
(Howard et al., 1999).  With respect to AIs undergoing surgical revascularization with CABG, 
mortality rates are reported to be higher than the general population and other ethnic groups 
(Nallamothu et al., 2001).  American Indians have historically experienced a low burden of 
cardiovascular disease.  However, the incidents of CHD in AIs are currently twice as high as 
Caucasians, and cardiovascular disease is now the leading cause of death for AIs (Espey et al., 
2014; Galloway, 2005; Sequist, Zaslavasky, Galloway, & Ayanian, 2006).  American Indians are 
36% more likely than Caucasians, to die prematurely due to heart disease (Savitz, 2012), and 
they have the highest prevalence of combined risk factors for CVD (tobacco use, diabetes, 
hypertension, hyperlipidemia) with >80% having one or more, and over one-third with three or 
more (Galloway, 2005).  Further, AIs have higher incidents of modifiable risk factors including 
diabetes mellitus, obesity, hypertension, physical inactivity, and smoking that contribute to the 
overall morbidity and mortality related to cardiovascular disease.   
Type 2 diabetes is a serious global public health problem, which affects disadvantaged 
populations disproportionately, especially AIs.  Compared with the US general population, AIs 
are 2.3 times more likely to be diagnosed with diabetes and the prevalence of associated 
comorbidities is 50% higher (Gittelsohn & Rowan, 2011).  In 2009, the age-adjusted prevalence 
of diabetes for adults eligible for Indian Health Service (IHS) was 16.1%, which is more than 
twice that of non-Hispanic white adults (Jiang et al., 2013).  Diabetes mellitus is the strongest 
emerging risk factor for AIs in the rising incidents of CHD (Sequist et al., 2006).  Most patients 
with type 2 diabetes are obese, and the global epidemic of obesity largely explains the dramatic 
 3 
 
increase in the incidence and prevalence of type 2 diabetes over the past 20 years (Eckel et al., 
2011). 
Obesity has been associated with type 2 diabetes as well as other chronic diseases, 
including heart disease, stroke, and certain types of cancers (Slattery et al., 2010).  The incidence 
of obesity has been increasing at disturbing rates worldwide.  According to Davies and Mullan 
(2014), worldwide obesity rates have doubled since 1980, and currently more than 35% of adults 
are obese.  This epidemic is associated with higher mortality risks, higher health care costs, 
impaired physical functioning, lower quality of life, and higher morbidity from major 
cardiovascular and non-cardiovascular causes (Hankinson et al., 2013).  Those that are 
overweight and obese are associated with excess cardiovascular and non-cardiovascular deaths in 
the general population; central obesity is directly associated with higher mortality in individuals 
with CAD (Coutinho et al., 2011).  In a study conducted by Jernigan, Duran, Ahn, and Winkleby 
(2010), AI reported higher obesity rates (23.9% versus 18.7%) and decreased leisure time 
physical activity (32.5% versus 27.5%).  In another study, thirty-six percent of AI men and 41% 
of AI women are considered obese as compared to 27% Caucasian males and 30% Caucasian 
females (Eschiti, 2005).  Obesity has contributed greatly to the epidemic of diabetes that is 
currently  afflicting this population; more than 75% of middle-aged and older AI men and 
women are overweight, with the majority exhibiting central obesity (Gray et al., 2000).  
According to Hall et al. (2010), obesity is associated with a cascade of metabolic and 
cardiovascular disorders, including hypertension, a primary mediator of obesity-induced 
cardiovascular disease.  
Hypertension is a significant risk factor in CVD, affecting an estimated 76.4 million US 
adults (Graham, Yancy, Boehm, & Wendt, 2012).  As reported in the Racial and Ethical 
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Approaches to Community Health survey data, Galloway (2005) reported AI men had the 
highest prevalence of hypertension and high blood cholesterol.  As reported by Hassan Talukder 
et al. (2011) smoking is a major independent risk factor for cardiovascular disease (CVD), 
including hypertension.  
Smokers have a 70% higher risk for CVD compared to non-smokers (Kurian & 
Cardarelli, 2007); cigarette smoking among AI ranged from 21.2% in the Southwest to 44.1% in 
the Northern Plains.  American Indian’s have the highest smoking prevalence of any ethnic 
group, 40.4%, compared with 27.4% among non-Hispanic Whites (Jernigan et al., 2010).  
Individuals who continue to smoke after experiencing a myocardial infarction have a 50 % 
higher risk of recurrent coronary events compared to nonsmokers.  With those who stop smoking 
after a myocardial infarction, the risk of coronary events declines over time so that their risk is 
equal to that of nonsmokers by three years after smoking cessation (Mohiuddin et al., 2007).  
Overall, AIs have a greater prevalence of known risk factors for CAD.  When compared 
to other racial and ethnic groups,   AIs have the highest prevalence of CVD at 16.4 %; the 
prevalence of diabetes increased by 26.9%, obesity increased by 25.3%, hypertension increased 
by 5%.  American Indians have the highest smoking prevalence of any racial group 40.4% 
compared with 27.4% among Caucasians (Jernigan et al., 2010).   
Aggregate data collected from IHS from 1989 to 1991 and 1996 to 1998 shows that the 
CVD mortality rates among AIs increased by 16% whereas this rate declined in all other racial 
minorities and in the Caucasian population (Jernigan et al., 2010).  In a recent study by Dyke et 
al. (2013), AIs present to the hospital with higher levels of acuity as well as higher prevalence of 
comorbid conditions than non-AI.  With the increase in comorbidities, they frequently required 
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resuscitation prior to surgery and were more likely to need urgent or emergent revascularization, 
placing them in a high-risk category for surgery.   
Problem Statement  
American Indians have a two-fold higher incidence rate of cardiovascular disease than 
other racial and ethnic groups in the United States (Howard et al., 1999; Nallamothu et al., 
2001).  When they present to the hospital, they are usually more acutely ill, requiring 
resuscitation at higher rates than non-AI.  In 2013, Dyke et al. reported that AIs had longer 
hospital stays compared to non-AIs, and continued to state that they had lower survival estimates 
in the medium-term (4.5%) compared to non-AI population beginning approximately one year 
following surgery.  According to Hadjinikolaou, Klimatsidas, Iacona, Spyt, and Samani, (2010), 
medium-term survival following CABG surgery is defined as 30 days up to five years.  
Understanding this disparity and identifying potential causes is needed to reduce health care 
disparities in AI following surgical coronary revascularization.  Under prescribing of 
recommended ACCF/AHA guideline-directed medical therapy after CABG in AIs as well as 
non-AI patients is potentially a causative factor increasing mortality.  The prevention of 
cardiovascular morbidity and mortality is a shared responsibility among all health professionals 
involved in the care of people at risk for cardiovascular disease (Merz et al., 2009).    
Project Design and Objectives 
The purpose of this project was to improve medical care by evaluating the utilization of 
current evidenced-based practice (EBP) in prescribing ACCF/AHA guideline-directed medical 
therapies, and improving access to appropriate medical follow-up.  The purpose of this project 
was met through the following objectives: 1) Identified inconsistencies between current provider 
practices and ACCF/AHA evidenced-based practice treatment guideline for AIs post CABG, 2) 
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Examined provider treatment plans between AI and non-AIs post CABG, 3) Determined patient 
adherence to the prescribed discharge treatment plan.  4) Develop recommendations for 
treatment plans post-CABG surgery in AI patients and recommendations for follow-up visits and 
post-CABG care.   
This project was designed as a retrospective chart review to examine the medical records 
of 100 AI patients and 100 medical records of non-AI patients.  The development of a chart audit 
tool was completed and used to document necessary information to meet the project objectives.  
The current ACCF/AHA evidenced-based guideline for the management of patients’ post-CABG 
was used as a basis for guideline-directed medical therapy (Hillis et al. 2011).  Additionally, the 
ACCF/AHA guideline provide guidance regarding the coordination of follow-up medical care 
with cardiovascular surgery, cardiology, and the individual’s primary care provider for the 
management of comorbid conditions, especially diabetes mellitus and hypertension, along with 
smoking cessation if applicable.  
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CHAPTER TWO. REVIEW OF LITURATURE 
There are an estimated 4.9 million persons, in 565 federally recognized tribes, who are 
classified as American Indian (AI) or Alaskan Native, making up approximately 1.6% of the 
U.S. population (Horowitz, 2012).  American Indians represent a diverse group of individuals 
living across the United States, and various tribes have different histories, languages, cultural 
beliefs, and traditional practices.  Many tribal nations suffer from a disproportionate burden of 
health problems including cardiovascular disease, diabetes, hypertension, fair/poor perceived 
health status, and current tobacco use.  Moreover, low socioeconomic status is an important risk 
factor for virtually all chronic diseases and conditions, especially those related to cardiovascular 
disease (CVD) (Levin, Lamar Welch, Bell, & Casper, 2002).  Additionally, the complications 
related to CVD are chronic, slowly progressive, and cumulative, eventually leading to occlusion, 
ischemia, and the need for a coronary artery bypass graft (CABG) surgery (Finn, Nakano, 
Narula, Kolodgie, & Virmani, 2010).    
Coronary artery bypass graft surgery, one treatment modality for CVD, can help to 
restore blood flow to an area of the heart.  “Coronary artery bypass surgery is the most durable 
and complete treatment of ischemic heart disease” (Kulik et al., 2015, p. 1).  However, surgery 
does not stop the progression of CVD.  A number of factors increase the risk of developing or 
speeding the progression of heart disease including smoking, diabetes, hypertension, and obesity.  
Comprehensive risk factor management reduces these risks associated with CVD (Kulik et al., 
2015).  
The American College of Cardiology Foundation (ACCF) and the American Heart 
Association (AHA) has jointly produced guideline in the area of cardiovascular disease.  The 
authors stated, “clinical practice guideline can provide a foundation for other applications, such 
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as performance measures, appropriate use criteria, and both quality improvement and a clinical 
support tool” (Hillis et al., p. e654).  This practice guideline are intended to assist healthcare 
providers in clinical decision making by describing a range of generally acceptable approaches to 
diagnosis, management, and prevention of specific disease conditions, with a goal to improve 
quality of care (Hillis et al., 2011).  One widely used approach is the use of guideline directed 
medication therapy.  
 Medication adherence is associated with improved outcomes among patients with CVD 
(Ho, Magid, Masoudi, McClure, & Rumsfeld, 2006).  Furthermore, Ho et al. (2006) reported that 
patients receiving any cardioprotective medication had lower mortality compared to those that 
had not received the medications.  Using medication therapy after coronary incidents to reduce 
mortality has proven effective in the reduction of morbidity and mortality.  According to 
Bouchard et al. (2010), measures of preventative treatment, including the use of beta-blockers 
and statin medications, have significant benefits after CABG surgery.  The benefit to 
postoperative use of beta-blockers following CABG reduces the incidence or clinical sequel of 
atrial fibrillation and both beta-blockers and statin therapy have shown an overall reduction in 
perioperative death (Bouchard et al., 2010; Hillis et al., 2011).  Despite evidence supporting the 
use of beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and lipid lowering agents 
in eligible patients  after CABG surgery, adoption of these secondary prevention measures has 
been inconsistent (Williams et al., 2011).  These inconsistencies may be multifactor; including 
bias in the pattern of care, active versus passive participation in stages of care, and physicians' 
awareness of and compliance with the guideline.  American College of Cardiology Foundation 
and the American Heart Association (ACCF/AHA) guideline are based on evidenced-based 
practice and demonstrate conclusively that beta-blockers, ACE inhibitors, statins, and aspirin 
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therapy decrease morbidity and mortality in CABG and acute myocardial infarction patients 
(O’Gara et al., 2011).  
Hillis et al. (2011) discussed the efficacy and the use of therapeutics post-CABG as well 
as smoking cessation and cardiac rehabilitation in the overall reduction in the risk of death post- 
CABG.  The authors stated that “lipid lowering therapy in CABG patients have demonstrated 
that lowering LDL cholesterol with statins influence post-CABG outcomes” (Hillis et al. 2011, p. 
e678).  Furthermore, they stated that improved survival was noted in all patient subgroups 
receiving beta-blockers.  In regards to ACE inhibitors, they reported that the drugs are known to 
exert cardiovascular protective actions, particularly in patients with left ventricular systolic 
dysfunction, hypertension, diabetes mellitus, or chronic renal insufficiency (Hillis et al. 2011).  
The ACCF/AHA practice guideline (Hillis et al., 2011) were intended to assist healthcare 
providers in clinical decision making by describing a range of generally acceptable approaches to 
prevent, diagnosis, and manage specific diseases and conditions.  As stated in the ACCF/AHA 
practice guideline, the Class of Recommendation (COR) is used to estimate the treatment effect 
considering risks versus benefits.  In addition, Hillis et al. provide evidence that a given 
treatment is or is not useful/effective in a certain situation and may even cause harm.   
History and Culture 
American Indians represent a diverse group of individuals living in all geographic regions 
of the United States; various tribes have different histories, languages, cultural beliefs, and 
traditional practices.  In North Dakota, the American Indian population is 6.4% of the total 
population, and approximately 55% of the population lives on one of the five Tribal Nations 
(North Dakota Indian Affairs Commission, 2010).  According to the United States Census 
Bureau (2012), AIs represent approximately 1.2% of the total population of Minnesota.  This 
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project focused on two AI Tribal Nations; the Sisseton-Wahpeton Oyate Nation, located in 
Southern North Dakota/Northern South Dakota and the Red Lake Nation located in Northern 
Minnesota.  While each Tribal Nation is unique, many AI communities have similar 
characteristics: close family relationships, identifiable communities, small community size, 
strong community support, and deep spiritual beliefs ("Cultural Competency: Serving American 
Indian Patients," 2010).   
According to AI history, each tribe had one or more elders who were groomed in the 
healing arts.  These individuals served as herbalists, healers, and spiritual communicators.  
Healing practitioners have passed many of the healing practiced and spiritual ceremonies on to 
the next generation of healers.  The understanding of traditional Indian medicine by many 
scientists, lay persons, and New Age healers, are not based on purely traditional teachings but are 
a mix of AI ceremonies, new age spirituality, and western medicine.  As a result, the 
understanding of tradition medicine remains meager, fragmented, and often distorted (Rhoades, 
2000).  Although the recognized AI Tribal Nations in North America do not comprise a 
monolithic group, their communities share many elements in their healing traditions (Horowitz, 
2012).  A generally accepted AI concept of health is that it is a tangible reality, not simply the 
state of being free of disease.  This health, or wellness, is often described as the ability to exist in 
a harmonious relationship with all other living things, but also with a number spirits, including a 
great and all-powerful spirit (Rhoades, 2000).  American Indians hold a holistic perspective on 
health based on a balance of the interrelationship of body, mind, spirit, and the environment 
(Horowitz, 2012).  Many of the healing practices link to spirituality and do not separate the 
mind, body, and spirit.  Healing practices are not recorded and may never be, as they are 
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considered sacred, private knowledge, and revealed only to certain members of the tribe through 
visions or initiations (Carlock, 2006). 
Although different Nations have distinct cultural values, traditions, and customs, there are 
a number of beliefs commonly shared among many AI people.  Illness or disease is believed to 
occur due to spiritual problems (Carlock, 2006).  American Indian communities include extended 
families and holistic problem solving.  Indian culture holds traditional healing rituals that focus 
on restoring the balance of physical, emotional, mental, and spiritual well-being.  All aspects of 
life are important and need to be balanced.  Health is achieved by maintaining balance and 
harmony within oneself and between oneself and the external world (Carlock, 2006).  If 
important aspects of life are ignored, life will be unbalanced and more difficult.  Symbolic 
healing rituals may involve entire communities and include singing, dancing, and drumming 
ceremonies (Ryback & Decker-Fitts, 2009).   
  Cultural beliefs are deeply rooted in the lives of many AIs and these beliefs significantly 
influence their health seeking behaviors.  Historical mistrust of outside organizations is a 
frequent barrier among many American Indian communities due to previous experiences and 
stereotypes (Horowitz, 2012).  Healthcare providers need to incorporate traditional healing 
practices and be aware of cultural beliefs regarding healthcare and healing practices in order to 
reduce the disparities.  Collaboration with traditional AI healers can improve health outcomes for 
AI patients (Rybak & Decker-Fitts, 2009).  Additionally, healthcare provider awareness of 
historical influences and specific cultural beliefs of various tribes will help to provide culturally 
sensitive care and establish a trusting relationship between the provider and the patient.   
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Sisseton-Wahpeton Oyate Nation 
The Sisseton-Wahpeton people consist of two joined bands of the eastern Dakota Nation 
(Garcia et al., 1997).  These two originally inhabited lands in Canada and Minnesota, as well as 
North and South Dakota (Gagnon, 2011).  The Lake Traverse Reservation located in South 
Dakota and southern North Dakota was established with the signing of the Lake Traverse Treaty 
of 1867.      
Many cultural beliefs and practices are shared between tribal nations; Sioux basic beliefs 
are derived from the revelations of supernatural Beings to the people through direct teaching and 
dreams (Gagnon, 2011).  The Sisseton-Wahpeton people believe that White Buffalo Calf Woman 
came to the Dakota-Lakota-Nakota Nation to provide the sacred pipe and the seven sacred 
ceremonies (sweat lodge, vision seeking, sun dance, hunka, buffalo sing, spirit-keeping 
ceremony, and throwing the ball).  Some of these sacred ceremonies are regularly performed 
today, including the sweat lodge and Sun Dance (Gagnon, 2011).  Traditional healers and 
medicine men continue to influence the AI people through their wisdom and knowledge of 
religious ceremonies.  
Red Lake Nation 
Ojibwes, or Chippewa, are a people of the Great Lakes region in both the United States 
and Canada.  Red Lake Nation is a federally recognized Indian reservation and is one of the few 
completely sovereign reservations in the United States.  Red Lake Nation established its 
independence on July 6, 1889 following the culmination of negotiations that established the 
sovereignty of the Red Lake Band of Chippewa Indians (http://www.redlakenation.org).   
Ojibwes believe in the Creator, who is neither male nor female.  The Creator shares 
power with others (the trees, plants, animals, water, other spirits and people) that are often 
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messengers for the Creator, bringing the Midewiwin (a religious society of healers dreams and 
spirit guides (Dwyer & Adare, 2013).  Depending on local traditions, there are four or eight 
levels of Midewiwin; its members are called Mide.  Native healers have traditionally been given 
the same respect as modern day doctors because they can use herbs to treat the sick.  The 
Midewiwin believe that living a patient, moderate, truthful, and respectful life, combined with 
using medicine plants given by the Creator, prolongs life (Dwyer & Adare, 2013). The changing 
nature of disease has led to alterations in traditional ceremonies and medical practices (Hill, 
2003). 
A Culture of Poverty 
 American anthropologist, Oscar Lewis in 1961, introduced the concept of a culture of 
poverty.  The culture of poverty theory is explained as those who find themselves in the grips of 
the poverty class, for whatever historical reasons, acquire a set of beliefs and values congruent 
with that status and the limitations it imposes (Graves, 2003).  According to Gorski (2008), the 
premise of the culture of poverty paradigm remains the same: that people in poverty share a 
consistent and observable culture that perpetuates poverty from one generation to the next; the 
individuals feel marginalized, helpless, inferior, and adopt an attitude of living for the present.   
These socioeconomic factors are likely contributing to healthcare disparities in the AI 
population.  Nearly one quarter of AI families are living below the federal poverty line, a rate 
that is 143% higher than whites (Hutchinson & Shin, 2014).  According to Hawkins, Jhund, 
McMurray, and Capewell (2012) numerous challenges face people of poverty including 
affordability of drug regimens, transportation costs, limited access to healthcare, inequalities in 
treatment, and fewer contacts with medical providers. Socioeconomic status is a powerful 
predictor of incident coronary disease and adverse cardiovascular outcomes (Hawkins et al., 
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2012).  As a result, socioeconomic status (SES) directly affects the health of individuals, and 
living in poverty reduces one’s access to healthcare.  
Indian Health Services 
 The Indian Health Service (IHS), an agency within the Department of Health and Human 
Services, is responsible for providing federal health services to American Indians and Alaska 
Natives.  According to IHS, the organization is the principal federal health care provider and 
health advocate for Indian people with the goal to raise their health status to the highest possible 
level (http://www.ihs.gov).  Indian Health Service provides a comprehensive health service 
delivery system for approximately 1.9 million American Indians and Alaska Natives who belong 
to 566 federally recognized tribes in 35 states.  The current IHS consists of three branches: 1) a 
federally operated direct care system, 2) an independent tribally operated health care facilities, 
and 3) a small urban health care program (Sequist et al., 2010).  Services offered by IHS include 
comprehensive primary care, specialty services, and prescription drug coverage.  However, 
inadequate funding of IHS has adversely impacted AI people by reducing access to health 
promotion and disease prevention interventions (Warne, Kaur, & Perdue, 2012).  
 Furthermore, according to Holm et al. (2010), the IHS operates with only 59% of the 
necessary resources to provide high-quality care.  Interestingly, per capita healthcare spending by 
the federal government is twice as high for prisoners compared to healthcare spending for 
American Indians.  Payments for services are paid to providers on behalf of IHS for individuals 
in need of private sector screenings, procedures, or diagnostic testing if funding is available; 
unfortunately, contract health services funding is not typically sustained for the whole fiscal year 
(Warne et al., 2012).  Lack of adequate funding for contract health services may lead to 
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restrictions in access to specialty services, such as cardiac rehabilitation, and access to 
cardiologists, creating a greater burden of health disparities among AIs. 
 Indian Health Services Director ADM Charles Grim approved the IHS National 
Pharmacy and Therapeutics Committee (NPTC) in February 2004.  The original charge was to 
look at the development of a national formulary due to the substantial increases in the cost of 
pharmaceuticals nationally, to improve quality of care, and to look at the use of formulary 
decisions as a cost management tool (http://www.ihs.gov/nptc/index.cfm).  A review of the 
current IHS formulary 
(http://www.ihs.gov/nptc/documents/formulary/NationalCoreFormulary.pdf) includes the current 
ACCF/AHA recommended guideline-directed medical therapy (Hills et al., 2011) such as beta-
blockers, angiotensin-converting enzyme (ACE) inhibitors, and high intensity statin therapy.    
Sanford Health 
Sanford Health is an integrated health system headquartered in the Dakotas and is now 
the largest rural, not-for-profit health care system in the nation with locations in 126 
communities in nine states.  Sanford’s mission is “dedicated to the work of health and healing, 
with a vision of improving the human condition through exceptional care, innovation, and 
discovery” (http://www.sanfordhealth.org).  In addition to strong clinical care, Sanford is also 
committed to engaging in medical research to discover innovative ways to provide care and cure 
for common diseases.  
Theoretical Framework 
Many social, cultural, and economic factors contribute to the development, maintenance, 
and change of health behavior patterns (Glanz & Bishop, 2010).  Social ecological models 
(SEM) recognize individuals as embedded within a larger social system and describe the 
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interaction characteristics of individuals and environments that underlie health outcomes (Golden 
& Earp, 2012).  The SEM describes the healthfulness of a situation and the well-being of its 
individuals are assumed to be influenced by both the physical and social environments as well as 
personal attributes of the individual (Pender, Murdaugh, & Parsons, 2014).  The SEM is intended 
to promote well-being; however, the interdependence among all components and levels of the 
environment must be taken into account.  This project looks at the individual patient and his or 
her treatment plan.  If applicable, the situation would require an organizational change to ensure 
ACCF/AHA guideline-directed medical therapies are being followed to optimize management of 
this patient population.  Following discharge, the patient returns to their home community, and if 
they are AI, the individual may seek follow-up care at the local IHS.  The social ecological 
approach integrates person-focused efforts to modify a person’s health behavior with 
environmental-focused interventions to enhance their physical surroundings (Stokols, 1996).  
Improving the health of AIs in the post-CABG phase of care may require interventions that 
target multiple levels of influence, in various settings; this would fit the basis of the model.  
Minkler (1999) states that individuals developmental histories and their social support system, 
along with organizational structures and processes can positively or negatively affect their health 
behavior.  This includes community-mediating structures such as schools, neighborhoods, and 
churches, community networks and power structures.  The content of our public policies are the 
key components of a broad socio-ecological perspective and essential determinants of health and 
health behavior.  The SEM functions beyond focusing solely on environmental factors to include 
transactions of the individual and groups with the environment.  Although this is a major 
strength, identifying the critical determinants that can be realistically targeted for change can be 
challenging (Pender et al., 2014).  
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The goal of this project was to provide an opportunity for individuals to make positive 
health changes and to develop a strong support system willing to assist them in the necessary 
changes.  Secondly, the organization (Sanford Health) will make necessary process changes to 
ensure ACCF/AHA guideline-directed medical therapies are followed and the treatment plans 
are communicated to individual’s primary care provider.  Indian Health Services in turn should 
continue the treatment plan as prescribed encouraging patients to make the necessary lifestyle 
changes to decrease the risk of early mortality related to cardiovascular disease.  
Conclusion 
 In summary, AIs experience significant health disparities compared to the general United 
States population.  Furthermore, AIs have higher incidents of modifiable risk factors including 
diabetes mellitus, obesity, hypertension, physical inactivity, and smoking that contribute to the 
overall morbidity and mortality related to cardiovascular disease.  The adherence to ACCF/AHA 
evidenced-based guideline in CAD will assist providers in delivering care that has the potential 
to improve overall health, enhance quality of life, and reduce disparities in not only the AI 
population but also all racial and ethnic groups.    
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CHAPTER THREE. PROJECT DESCRIPTION 
Project Implementation 
 The practice improvement project was an evidence-based intervention plan based on 
results of an extensive literature review.  Data from numerous research studies indicated the need 
to develop interventions to reduce risk factors, prevalence, and mortality rates for cardiovascular 
disease in the AI population (Cho et al., 2014; Eschiti, 2005; Espey et al., 2014; Galloway, 2005; 
Kurian & Cardarelli, 2007; Veazie et al., 2014).  Understanding these disparity and identifying 
potential causes is needed to reduce health care disparities in AI patients following surgical 
coronary revascularization.  
 Although AIs are 36% more likely than Caucasians, to die prematurely due to heart 
disease (Savitz, 2012), secondary prevention measures are effective in reducing morbidity and 
mortality.  Secondary prevention focuses on early detection and treatment of disease, with the 
purpose to cure disease, slow its progression, or reduce its impact on individuals or communities 
(Smith et al. 2011).  According to McLeod, Brooks, Taylor, Currie, and Dewhurst (2004), 
secondary prevention measures for coronary heart disease are effective in reducing coronary 
morbidity and mortality.  Measures commonly recommended by evidence-based guideline to 
improve cardiac risk factors include prophylactic drug therapy (anti-platelet agents, beta-
blockers, statin therapy, and ACE inhibitors), lifestyle changes, and risk factor control (smoking 
cessation, dietary modification, and weight reduction).  The ACCF/AHA guideline for coronary 
artery bypass graft surgery was used as the evidenced-based guide in the development of this 
project.  This guideline demonstrates conclusively that recommendations, if followed, decrease 
morbidity and mortality following CABG (O’Gara et al., 2011). 
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Not only is there a need to increase secondary prevention in the outpatient setting, health 
care providers need to remain educated on existing and changing EBP guideline.  The prevention 
of cardiovascular morbidity and mortality is a shared responsibility among all health 
professionals involved in the care of people at risk for cardiovascular disease (Merz et al., 2009).   
Project Description 
Healthcare providers are responsible for 1) providing education regarding disease and the 
processes associated with the disease, 2) continuing chronic medication therapies to aid in the 
reduction of morbidity and mortality related to cardiovascular disease, and 3) to ensuring 
adequate follow-up care are available and attainable to the individual patient.  The purpose of 
this project was to improve medical care by using current EBP in prescribing ACCF/AHA 
guideline-directed medical therapies, and to improve access to appropriate medical follow-up.  In 
turn, this project identified potential causes related to short and medium term mortality rates in 
AI patients following surgical coronary revascularization.  The health care disparity that exists in 
the AI population may be multi-factorial including co-morbid conditions, less intensive medical 
follow-up, and access to medications known to reduce cardiovascular risk factors.  A better 
understanding of the causative factors leading to increased mortality in AI patients post-CABG 
surgery provide directions for further efforts by providers to improve outcomes not only in post-
CABG patients, but also in all patients with coronary artery disease.   
Preliminary data collected from Dyke et al. (2013) identified 1,365 patients who 
underwent CABG surgery at Sanford Health Fargo between the years of 2008-2012, of which 83 
were identified as AI (6.1%).  This is similar to the 2010 Census Bureau data for the population 
of AIs in North Dakota.  American Indian patients appeared to be younger, sicker, and having a 
greater number of cardiovascular risk factors than non-AIs on presentation to the hospital; thus, 
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they required urgent or emergent surgery and were less likely to be afforded the opportunity to 
undergo surgery on an elective basis.  
The purpose of this project was to improve medical care by evaluating the utilization of 
ACCF/AHA guideline-directed medical therapies, and improving access to appropriate medical 
follow-up.  The purpose of this project was met through the following objectives: 1) Identified 
inconsistencies between current provider practices and ACCF/AHA evidenced-based practice 
treatment guideline for AIs post CABG, 2) Examined provider treatment plans between AI and 
non-AIs post CABG, 3) Determined patient adherence to the prescribed discharge treatment 
plan.  4) Develop recommendations for treatment plans post-CABG surgery in AI patients and 
recommendations for follow-up visits and post-CABG care. 
This project was a retrospective chart review to examine the medical records of 100 AI 
patients and 100 medical records of non-AI patients.  Thorough evaluations of allergies, 
discharge medications, and follow-up care as well as notes were reviewed.  This data were 
quantified to identify potential deficiencies is practice in hopes of developing strategies for 
improving care.  Current ACCF/AHA evidenced-based guideline (Hillis et al., 2011) for 
management of patients following CABG surgery was used as a basis for guideline-directed 
medical therapy on reducing the morbidity and mortality of patients post-CABG.  The 
coordination of follow-up medical care with cardiology, cardiovascular surgery, and the 
individual’s primary care provider to management of comorbid conditions, especially diabetes 
mellitus and hypertension, along with smoking cessation if applicable can be a daunting task for 
individuals following a major health crisis.  
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Project Development 
 A meeting was scheduled with Dr. Dyke at Sanford Health Fargo, regarding the project 
and its possible impact on patient outcomes.  Then a literature review was preformed to learn 
about the AI culture and evidenced-based articles relating to CABG.  This review formed the 
groundwork for the proposed project.   
 Data were collected through a retrospective Electronic Chart Audit (ECA).  The ECA 
measurement tool was developed based on the 2011 ACCF/AHA Guideline for CABG.  
Additionally, this ECA tool was reviewed by experts in the field of survey development, public 
health, medicine, and cardiovascular disease for validity.  Minimal changes were made to the 
draft of the audit tool after consultation (Appendix B).  The audit tool included patient 
demographics (age, gender, body mass index, and current smoker), disease processes, and 
comorbidities, cardiac presentation at the time of admission, medications at discharge, and 
follow-up appointments.  The author is employed at Sanford Health; therefore, he was 
comfortable with the electronic medical records and the medical terminology used in the patient 
charts.  He verified that the data on the ECA tool was documented in EMR.  Interpreter 
reliability was not assessed because it was only the author collecting data.  
After approval from North Dakota State University Institutional Review Board along 
with Sanford Health Institutional Review board, the electronic medical records of the previously 
identified 100 AI were studied along with 100 non-AI medical records of similar demographics.  
The charts were dissected and clinical data that was collected was retrospective.  Data collection 
included patient demographics, age, gender, allergies, date of admit, date of surgery, and date of 
discharge.  Discharge order sets were reviewed and a list of discharge medications was compiled 
for each patient.  The dates of follow-up appointments with primary care providers, cardiology, 
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and cardiovascular surgery were noted.  Provider notes post-discharge were examined and 
medication changes were noted.  When statistical analysis was completed, ACCF/AHA guideline 
for post-CABG (Hillis et al., 2011) were examined and compared with current Sanford Hospital 
discharge algorithms.   
Institutional Review Board Approval 
The human subjects for this project were patients that had previously undergone CABG 
surgery at Sanford Health Fargo, North Dakota between the years of 2008-2013, which included 
women and minorities.  However, no children were included in the project.  This practice 
improvement project did not involve direct patient contact; thus, there was little to no risk to the 
patients throughout the entirety of the project.  Potential risks in this project were minimal as it 
was a retrospective design reviewing medical records.  The North Dakota State University 
Institutional Review Board, as well as Sanford Health, Fargo, North Dakota granted protection of 
human subjects.    
Potential benefits of this evidence-based project include a better understanding among 
healthcare providers of AI culture, barriers to healthcare, and prescribing practices of medication 
therapy after CABG surgery.  Additionally, providers will be strategic with establishing frequent 
medical follow-up care, both within the organization and in satellite clinics, to reduce mortality 
in AI following CABG surgery.  Heightened awareness of prescribing practice and follow-up 
medical visits will assist healthcare providers in creating more effective and culturally sensitive 
treatment options.  This project has a high potential to benefit both healthcare providers and the 
AI population following surgical coronary revascularization.  
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Data Collection 
Data collection related to this project had several obstacles.  First, Sanford Health Fargo 
adopted an EMR in 2011.  Patient related data is currently located in the EMR One chart as well 
as in the previous system Centricity.  Access to Centricity is currently restricted to medical 
doctors, nurse practitioners, and physician’s assistants.  Students are not given access to 
Centricity without prior authorization.  Access for the author was requested on two occasions 
and was granted after a written request from Dr. Dyke.  The second limitation was related to the 
information technology department at Sanford Health Fargo.  Multiple requests were sent to 
Sanford’s IT department for the development of an electronic query to gather data regarding AI 
and non-AI post-CABG patients between the years of 2008-2013.  According to Sanford’s 
Information Technology Department, they were unable to be complete the request for the 
development of a query due to time constraints and lack of resources.  However, requests for 
queries were not consistent; queries have been granted on other recent projects.  As a result, data 
collection was conducted by the author by manually searching for post-CABG patients that met 
the selected criteria.   
A request for remote access (the ability to access medical records via the internet for a 
location other than Sanford Health) to both of Sanford Health’s EMRs (Epic’s One Chart & 
Centricity) was also denied on multiple occasions.  Remote access is granted for medical 
providers however, it excludes residents and students, further limiting convenient access to data 
collection.  The ability to access the medical records relating to this project proved to be more 
difficult than initially anticipated.  Computer availability and a secure location in which to access 
patients medical records at Sanford Health was also limited, as office space or research friendly 
space is at a premium.     
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Patients for this study were identified from the previous study conducted by Dyke et al. 
(2013) at Sanford Health Fargo.  The AI patient population was determined by the patients that 
had CABG surgery at Sanford Health Fargo from the years 2008-2013 and who self-identified 
themselves as American Indian on the initial hospital admission form.  The patient’s that 
identified themselves as AI were separated from the non-AIs and the patient’s medical record 
number (MRN) was input into the EMR and data was sought and recorded on the Electronic 
Chart Audit tool for each individual patient.  Once data collection of the AI group was done, a 
1:1 match of the AI group with the non-AI group using the basic demographic information of 
patient age and sex was completed.  The MRN numbers of the non-AI patients was used in the 
same fashion and data recorded on the Electronic Chart Audit tool.       
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CHAPTER FOUR. EVALUATION 
The social ecological model (SEM) views the individual in the context of their families, 
communities, and cultures, emphasizing the relationships among environmental, biological, and 
behavioral determinants of health.  The SEM also focuses on interactions between a person's 
physical, social, and cultural surroundings, and therefore, it is believed to provide the best 
approach in efforts to prevent increasing mortality rates in all ethnic groups (Caprio et al. 2008).  
The SEM defines the theoretical framework used to evaluate the objectives of this 
project.  Health behaviors of the individual or patient (inner oval) are influenced by 
interpersonal, organizations, community, and public policy domains represented by the 
progressively larger ovals.  For the purpose of this project, the organization included Sanford 
Health, IHS, and various medical clinics within the region.  The public policy would be 
considered current evidenced-based guideline such as the ACCF/AHA guideline for coronary 
artery bypass graft surgery: A report of the American College of Cardiology Foundation and 
American Heart Association task force on practice guideline.  Many influencers may span more 
than one domain, however at the center remains as always the individual/patient.  The SEM goes 
beyond a focus solely on environmental factors to include transactions of the individual and 
groups with the environment.  Although this is seen as a major strength, identifying the critical 
determinants that can be realistically targeted for change can be challenging (Pender et al., 
2014).  Figure 1 shows an excellent representation of the project; again, the focus remains the 
individual.  In order to target appropriate change, we must look at the possible domains involved 
and guide interventions to target specific health behaviors as well as organizational change.  
The SEM is composed of interconnected elements, and considers how all these levels of 
influence can be addressed to support long-term, healthful lifestyle choices.  For the purpose of 
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this project, the individual is central, and concentric circles that affect the individual are ever 
changing.  Each of these elements influences the individual and without appropriate change at 
each level, the individual may feel overwhelmed and resist such change.   
The second element of the SEM is the interpersonal element.  Within this circle are things 
such as family, culture, and values.  This element is vital to personal change and involves the 
most dynamic elements in the individual’s life.  Family must be willing to change aspects of 
their lives in order to benefit the individual.  These factors include diet, exercise, and smoking 
cessation.  Within this element are cultural factors, such as the role of tobacco in traditional 
beliefs and ceremonies make tobacco cessation a challenging issue (Espey et al. 2014) in the 
American Indian population following CABG surgery.   
The third element is the organization, in this study the organization is both Sanford 
Health Fargo and IHS.  In order to better serve the individual, organizations must incorporate 
change as well to accommodate the needs of the individual.  As previously mentioned, IHS is in 
need of greater funding and specialty services to greater impact the health needs of the people.  
The fourth element of the SEM is considered the community.  Within the community are the 
individual’s neighborhood, city, and reservation.  The impact the community can have on the 
individual is endless.  The ability to embrace change at a community level can be a daunting task 
with the lack of financial support needed for change.  In the community, there should be a 
community or rehabilitation center that provides opportunities for cardiac rehabilitation and 
educational programs for smoking cessation, healthy eating classes, and the management of 
diabetes.   
The final element of the SEM is public policy; these include factors of the health, 
economic, educational, and social policies.  Indian Health Services along with the United States 
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government also play a role in this element of the SEM.  Greater resources are needed to support 
the needs of IHS and the AI people.  Policy change as well as budgetary change can have lasting 
effects on decreasing healthcare disparities of the AI people now and in the future.  The use of 
the SEM for a study as specific as CABG surgery patients is unusual, however the model 
provides the framework that was well suited for the best outcomes in the AI population.  The 
individual remains central and change must be multifactorial to be effective and long lasting.     
 
         U.S. National Library of Medicine 
Figure 1. Social Ecological Model 
 
Project Description                                                    
  This evidenced-based project was a retrospective study of patients who underwent CABG 
surgery at Sanford Health Fargo, North Dakota.  Data were collected and evaluated on 100 AI 
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patients as well as 104 non-AI patients.  The demographics of both populations were considered, 
and a 1:1 match of patient’s age and sex was performed via a retrospective chart audit utilizing 
Sanford Health’s EMR One Chart and Centricity.  The retrospective chart audit allowed for 
collection of pertinent data in determining if inconsistencies existed in the prescribed treatment 
plans of American Indians versus non-American Indians following CABG.  North Dakota State 
University’s statistics department performed statistical analysis.  Variables were analyzed via 
Chi-squared analysis and statistical significance was predetermined at the p < 0.05 level.  
Evidenced-Based Measures to Evaluate the Plan 
The evidenced-based measures used to evaluate the project included Hillis et al.’s (2011) 
ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American 
College of Cardiology Foundation/American Heart Association Task Force on Practice 
Guideline (see Appendix A for ACCF/AHA guideline).  This guideline for perioperative 
management of patients post-CABG surgery includes recommendations for antiplatelet therapy, 
management of hyperlipidemia, perioperative beta-blocker, and the use of ACE inhibitors/ARBs.  
The patient’s allergies and vital signs (systolic and diastolic blood pressure and pulse) at 
discharge were collected to ensure the prescribed medications at discharge were tolerated, as 
well as data regarding demographics to determine if comorbidities played a role in overall 
mortality rates. 
Evidenced-Based Measures/Instruments Used for the Objectives 
A retrospective chart audit was implemented using a retrospective Chart Audit Tool (see 
Appendix B for retrospective chart audit tool) for collection of pertinent data.  A retrospective 
study uses existing data that have been recorded for reasons other than research.  According to 
Cassidy, Marsh, Holleran, and Ruhl (2002), the patient’s medical record is often used as a 
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primary source of retrospective data for the purposes of epidemiological analysis and is 
considered the gold standard in any study to identify demographic factors, clinical data variables, 
specific aspects related to treatment regimens, and ultimately patient morbidity and mortality.  
This project used known AI patients who had undergone CABG surgery and then matched to 
non-AI patients of similar age and sex who also had undergone CABG at Sanford Health Fargo.  
The purpose of using a 1:1 comparison for data collection was to reduce the cofounding 
variables and to gain valuable knowledge if inconsistencies in prescriber practice existed 
between the two groups.  Another reason for this type of evidenced-based study allowed for a 
greater understanding of patient adherence to the prescribed plan of care and medical follow-up 
practices.    
Objective One 
To identify inconsistencies between current provider practice and ACCF/AHA 
evidenced-based practice treatment guideline for AIs post-CABG were evaluated using data 
collected from the retrospective chart audit comparing written discharge medications to the 
ACCF/AHA guideline previously discussed.  See appendix A for 2011 ACCF/AHA guideline 
for CABG surgery that provide recommended perioperative management in this patient 
population.  The data regarding the prescribing of discharge medications included beta-blockers, 
ACE inhibitors/ARB’s, lipid management, and antiplatelet agents for the AI group were 
collected and statistical analysis completed using descriptive statistics.      
Objective Two 
To examine inconsistencies between current provider practice and ACCF/AHA 
evidenced-based practice treatment guideline between AI and non-AIs post-CABG, was 
evaluated using data collected from the retrospective chart audit.  The data regarding the 
 30 
 
prescribing of discharge medications included beta-blockers, ACE inhibitors/ARB, lipid 
management, and antiplatelet agents for the AI group and also the non-AI group was collected 
and statistical analysis was completed using the chi-square test.  The data from the two groups 
were than compared for inconsistencies.     
Objective Three 
To determine patient adherence to the prescribed discharge treatment plan in AI post-
CABG at Sanford Health Fargo.  The data was collected using a retrospective chart audit and the 
pertinent information was gathered regarding follow-up appointments as well as medication 
changes at these appointments.  The prescribed treatment plan called for medical follow-up 
appointments with the cardiothoracic surgeon, cardiology, and the patient’s primary care 
provider.  The retrospective chart audit allowed for review of patients that had returned to 
Sanford Medical Center, Fargo, North Dakota for these specific appointments.  Provider notes 
were reviewed and documentation of medication additions, discontinuation, or changes  were 
reviewed to determine if they were  in accordance with the ACCF/AHA guideline indicating the 
provider met the standard for EBP.  Statistical analysis was completed using descriptive 
statistics. 
Objective Four 
The objective to develop recommendations for postoperative care and follow-up after 
CABG surgery was evaluated by using a retrospective chart audit form. The pertinent 
information was gathered regarding follow-up appointments and discharge medications.  
According to Rassaf, Steiner, and Kelm, (2013), patients with coronary heart disease should be 
followed up regularly (every three to six months) by their primary care physicians, independently 
of any additional visits that may be necessitated by worsening symptoms, comorbidities, or any 
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other tests that need to be completed.  The current recommendations for postoperative follow-up 
care per the cardiovascular surgeons at Sanford Health Fargo requires the patient to see 
cardiovascular surgeon two weeks and four weeks following discharge and as needed.  In 
addition, they should see cardiology in four-six weeks, and they should see their primary care 
provider (PCP) in one-two weeks after discharge.  The 2011 ACCF/AHA guideline was used as 
EBP for current guideline-directed medical therapy to include prescribing beta-blockers, 
angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB’s), 
high intensity statin therapy, and antiplatelet (aspirin) therapy at discharge.  Statistical analysis 
was completed using the chi-square test.   
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CHAPTER FIVE. RESULTS 
 In this practice improvement project the sample consisted of a total of 204 patients who 
had undergone CABG surgery at Sanford Health, Fargo, North Dakota between the years of 
2008-2013.  Of these, 100 patients (49%) were identified as AI (n=61 male).  This group was 
younger (61.3 vs 64.1 years; p<0.0306) than the non-AI group.  They were significantly more 
likely to be active tobacco smokers.  When analyzed there was no significant difference between 
the body mass indexes of the two groups.  Patient demographics information is presented in 
Table 1. 
Table 1. Demographic Information on American Indian and Non-American Indian CABG 
Patients 
Variable AI (n=100) % 
Non-AI  
(n=104) % p-value 
Age 61.3±9.2 
 
64.1±9.3 
 
0.031 
Range 
    
  
30-39 1 
 
1 
 
  
40-49  14 
 
7 
 
  
50-59 23 
 
21 
 
  
60-69 43 
 
43 
 
  
70 and older 19 
 
32 
 
  
Gender         0.717 
Female 39 39 38 36.5   
Male 61 61 66 63.5   
Current Smoker 56 56 29 27.9 <0.001 
BMI 31.8±6.1   31.3±5.4   0.594 
 
Cardiovascular risk factors such as the presence of diabetes mellitus and insulin-
dependent diabetes mellitus were significantly higher in the AI.  Preoperative end-stage renal 
disease requiring dialysis was more common in AI patients (7.0% vs 3.85%; p=0.3188) although 
this did not reach statistical significance.  Data regarding comorbid conditions and clinical 
presentation are presented in Table 2.  
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Table 2. Comorbid Conditions and Clinical Presentation of AI and Non-AI post-CABG Patients 
Variable  AI (n=100) % 
Non-AI 
(n=104) % p-value 
Diabetes 60 60 38.46(40) 38.5 0.002 
Controlled by: 
    
  
Diet  0 0 2 5 0.158 
Oral medication 23 38.3 23 57.5 0.060 
Insulin  37 61.8 15 37.5 0.018 
Hypertension 83 83 92 88.5 0.264 
Chronic Lung Disease 24 24 42 40.4 0.016 
  
    
  
Mild 13 54.2 27 64.3 0.418 
Moderate 6 25 6 14.3 0.278 
Severe 5 20.8 9 21.4 0.955 
Pre-Op Congestive 
Heart Failure 14 14 22 21.2 0.180 
Peripheral Vascular 
Disease 20 20 13 12.5 0.146 
Cardiovascular Disease 14 14 46 44.2 <0.001 
History of Cerebral 
Vascular Accident 6 6 5 4.8 0.706 
Hemodialysis 
Dependent  7 7 4 3.9 0.319 
Creatinine mg/dl 1.1±1.0   1.1±0.8   0.954 
Immunosuppressed 8 8 0 0 0.003 
Previous CABG 1 1 0 0 0.369 
Cardiac Presentation 
    
  
No Symptoms 6 6 1 0.9 0.061 
Stable Angina 7 7 22 21.2 0.004 
Unstable Angina 41 41 51 49 0.249 
NSTEMI 33 33 26 25 0.208 
STEMI 13 13 4 3.9 0.030 
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Table 2. Comorbid Conditions and Clinical Presentation of AI and Non-AI post-CABG Patients 
(continued) 
Variable  AI (n=100) % 
Non-AI 
(n=104) % p-value 
Surgical Status  
    
0.000 
Elective 12 12 29.81(31) 29.8 0.002 
Urgent 70 70 43.27(45) 43.3 0.000 
Emergent 18 18 26.92(28) 26.9 0.125 
History of Myocardial 
Infarction 47 47 55 52.9 0.401 
  
    
  
< 7 days Prior 41 87.2 38 69.1 0.029 
8-21 days Prior 1 2.1 4 7.3 0.230 
>21 days Prior 5 10.6 13 23.6 0.086 
Cardiogenic Shock 2 2 2 1.9 1.000 
Arrhythmias 6 6 17 16.4 0.020 
Resuscitation 2 2 3 2.9 1.000 
Left Main Disease 
(>50%) 39 39 43 41.4 0.733 
Ejection Fraction % 49.5±13.4   50.9±13.5   0.457 
ADP Inhibitors 33 33 12 11.5 <0.001 
Note. p > value 0.05 level for statistical significance  
American Indians presented to the hospital for CABG with a higher level of acuity than 
non-AI.  The incidence of ST-elevation myocardial infarction was significantly different between 
AI and non-AI groups (12.0% vs 3.85%; p= 0.0304), and non-ST-elevation myocardial infarction 
was more common in the AI group (33.0% vs 25.00%; p=0.2077).  More AIs presented on 
antiplatelet therapy (33.0% vs 11.54%; p=0.0002), they were more likely to require urgent 
revascularization (70.0% vs 43.27%; p=0.0001), and less likely to undergo elective surgery 
(12.0% vs 29.81%; p=0.0018).  American Indians were less likely to be discharged on a beta-
blocker (90.0% vs 97.12%; p=<0.0375). There was no difference in statin therapy, and aspirin 
utilization upon discharge.  Written Discharge Medications post-CABG in AI and Non-AI 
Patients are detailed in Table 3. 
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Table 3. Written Discharge Medications post-CABG in AI and Non-AI Patients 
  AI  (N=100) 
 Non-AI 
(N=104) Chi-Square p-value  
Beta-blocker 90.0% 97.0% 4.326 0.038 
ACE inhibitor/ ARB 26.0% 16.0% 2.856 0.091 
Statin Therapy 96.0% 90.0% 2.515 0.113 
Aspirin  96.0% 96.0% 0.003 0.955 
 
Objective One 
Objective one identified inconsistencies between current provider practices and 
ACCF/AHA evidenced-based practice treatment guideline for AIs post-CABG.  Data were 
collected using a retrospective chart audit of AI patients that had undergone CABG surgery at 
Sanford Health Fargo.  Statistical analysis of the data used frequencies of medications prescribed 
at discharge to identify inconsistencies in prescriber practice.  The results demonstrated that AIs 
were prescribed ACCF/AHA guideline-directed medical therapy at their discharge.  The 
prescribed medication included beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, 
or angiotensin II receptor blockers (ARB’s), statin therapy, and antiplatelet (aspirin) therapy at 
discharge.  
Objective Two 
Objective two examined provider treatment plans between AI and non-AIs post CABG 
using the retrospective chart audit of both AI and non-AI that had CABG at Sanford Health 
Fargo; Chi-square tests were conducted on the medication therapies prescribed at discharge for 
AI and non-AI post-CABG patients.  The results of the data chi-square test for beta-blockers was 
χ2=4.326, df=1, p=0.038; ACE inhibitor/ARB was χ2=2.856, df=1, p=0.091; statin therapy was 
χ2=2.515, df=1, p=0.113; and aspirin therapy was χ2=0.0032, df=1, p=0.955.  The results of the 
data collected displays that AIs and non-AI patients were prescribed ACCF/AHA  guideline-
directed medical therapy at discharge including beta-blockers, angiotensin-converting enzyme 
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(ACE) inhibitors or angiotensin II receptor blockers (ARB’s), statin therapy, and antiplatelet 
(aspirin) therapy.  The results comparing AI and non-AI post-CABG discharge medications are 
shown in Figure 2.
 
Figure 2. Medication Therapy Prescribed for AI and non-AI Post-CABG Patients at Hospital Discharge 
Objective Three 
Objective three determined patient adherence to the prescribed discharge treatment plan 
in the AI following CABG surgery at Sanford Health Fargo. Data collected were used for 
statistical analysis to determine if AI patients adhered to the recommended discharge treatment 
plans regarding follow-up medical appointments.  Statistical analysis of the data used 
frequencies to determine their adherence to prescribed discharge treatment plans.  The results of 
this project demonstrated AI patients were seen for follow-up care by a primary care provider 
(18%), cardiology (44%), and by cardiovascular surgery (95%).  
Objective Four 
 In objective four the prescribed discharge treatment post-CABG surgery for AI and non-
AI were compared.  Data was collected using the retrospective chart audit of 204 medical 
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records; 100 AI and 104 non-AI charts.  Chi-square tests were conducted on the data collected 
regarding discharge medical follow-up in both AI and non-AI patients.  The results of the data 
chi-square tests for follow-up appointments with cardiovascular surgery χ2=0.606, df =1, 
p=0.437; cardiology χ2=0.991, df=1, p=0.320; and a primary care provider χ2=20.753, df=1, 
p=<0.0001.  The results of the data showed statistical significance for AI patients compared to 
non-AI patients who saw a primary care provider following discharge; 18% of AI patients 
attended an appointment with their PCP compared to 48.08 % of non-AI patients.  The results of 
the data for the discharge medical follow-up appointments for AI and non-AI post-CABG are 
displayed in Figure 3.   
 
Figure 3. Discharge Medical Follow-up Appointments for AI and Non-AI Patients Post-CABG Surgery  
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CHAPTER SIX. DISCUSSION AND RECOMMENDATIONS 
Interpretation of Results 
 In this retrospective chart review, demographical data was presented on post-CABG 
patients (n=204) which consisted of AI patients (n=100) and non-AI patients (n=104). In a study 
conducted by Dyke et al., (2013) AIs were younger at time of surgery compared to non-AI 
patients. Consistent with Dyke et al. (2013) the AI patients in this study were also younger at the 
time of surgery (63.1 years vs 64.1 years). Additionally, more AI males than females required 
CABG in this review (n=61). Obesity is a known risk factor for coronary heart disease. In a 
study by Gray et al. (2000), more than 75% of middle-aged and older AI men and women are 
overweight.  When compared to previous studies, the findings from this study are similar.  AI 
patients had an average body mass index (BMI) of 31.8in contrast, to the non-AI patients who 
had a BMI of 31.3; a BMI greater than 30 is classified     
 In previous studies, AIs have been found to be a high-risk population for cardiovascular 
disease due to the high rates of diabetes mellitus, obesity, hypertension, and tobacco use 
(Jernigan et al., 2010; Kurian & Cardarelli, 2007; Sequist, Zaslavasky, Galloway, & Ayanian, 
2006).  In support of these previous studies, the findings of this study confirmed, that AIs have 
higher rates of diabetes (60% vs. 38.5% non-AI).  Additionally, active tobacco use in AI patients 
was two times that of non-AI patients (56% vs 27.9%).  Tobacco use has been associated with 
chronic lung disease.  The results of this study looked at current tobacco use, and the presence of 
chronic lung disease.  The results may not give a true representation of the population since AI 
patients presented to the hospital at a younger age and the effects of tobacco on their lungs may 
not be detected to this point.  When age groups of 70 years old and above are incorporated in 
with chronic lung disease, the non-AI patients have almost a 2:1 ration (19 vs 32) when 
 39 
 
compared to AI patients.  The AI patients had a greater prevalence of moderate and severe lung 
disease when compared to non-AI (45.8% vs 35.6%).  In contrast to previous reports, AI patients 
had decreased rates of hypertension when compared to non-AIs (83% vs 88.5%), and non-AI 
patients had reported greater incidents of cardiovascular disease when compared to AI patients 
(44.2% vs 14%).  In a study by Dyke et al. (2013), AI patients present to the hospital with a 
higher level of acuity than non-AI patients present, and were more likely to require urgent or 
emergent revascularization, placing them in a high-risk category for surgery.  In support of 
previous studies, the findings of this project confirmed that AI patients presented more acutely 
ill.  For example, AI patients presented to the hospital with an ST elevated myocardial infarction 
(STEMI) three times more often than the non-AI patients (12 vs 3).  In contrast, non-AI patients 
reported to the hospital with stable angina three times more often than AI patients (22 vs 7).  Six 
AI patients presented to the hospital without symptoms compared to none of the non-AI patients 
(6 vs 0); correlation could be made that this presentation is related to silent myocardial ischemia.  
Hernandez et al. (2011) reported that coronary artery disease is often asymptomatic in diabetic 
patients and silent myocardial ischemia is predictive of cardiovascular mortality.  The findings of 
this study supported Dyke et al. findings that AI patients require surgical revascularization more 
urgently.  American Indian patients presented to the hospital and underwent urgent CABG more 
frequently than non-AI patients (70 vs 45).  In contrast, non-AI patients had elective CABG 
surgery at rates greater than AI patients (31 vs 12).   
 The data collected regarding current ACCF/AHA Guideline for CABG surgery for 
guideline-directed medical therapy which included prescribing beta-blockers, angiotensin-
converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB’s), high intensity 
statin therapy, and antiplatelet (aspirin) therapy at discharge was reviewed during the 
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retrospective chart audit.  Despite the ACCF/AHA guideline, AI patients were less likely to be 
discharged on beta-blockers (90.0% vs 97.12%; p=<0.0375) when compared to non-AI patient.  
Another key point was the prescribing of ACE inhibitors or ARB’s upon discharge in both 
populations (26% AI and 16.35% non-AI) was problematic.  
 Patient adherence to the prescribed discharge treatment plan requires patients to return for 
routine outpatient appointments post-CABG.  The results of data collection regarding patient 
adherence to the prescribed discharge treatment plan in the AI patents post-CABG revealed AI 
patients had significant deficiencies in areas of follow-up care.  American Indian patients follow-
up rate with a primary care provider after discharge post-CABG was only 18% of the time 
compared to an approximate 48% of the time for non-AI patients.  American Indians patients 
were seen for return outpatient appointments by cardiology 44% compared to 51% for non-AI 
patients, and AI patients returned to the clinic 95% compared to 97% for non-AI patients to see 
the cardiothoracic surgeon.  Optimal medical therapy and improved outpatient care remains 
vitally important in these high-risk patients and opportunities to improve medical care exist for 
AI now and in the future.   
Limitations 
 The practice improvement project was associated with a number of limitations.  The first  
limitation was this retrospective study included patients from 2008-2013; the current EBP 
guideline are the ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery and was used 
as the gold standard for this project (Hillis et al. 2011).  The investigator decided not to use the 
previously published guideline by Eagle et al. (2004) because it did not address the use of pre or 
post-operative use of beta-blockers, or ACE inhibitors/ARB’s however, it did recommend aspirin 
as the drug of choice for prophylaxis against early saphenous graft thrombotic closure and should 
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be considered a standard of care for the first postoperative year.  All patients should be 
considered candidates for pharmacological low-density lipoprotein reduction post-CABG 
surgery if their low-density lipoprotein level exceeds 100 mg/dL (Eagle et al. 2004).   
A second limitation to this project was the sample size.  The total sample for this project 
was 204 patients.  As stated earlier, 100 patients were identified as AI, and 104 patients were 
identified as a race other than AI.  The number and selection of the patients may characterize the 
quality of a sample.  A large matched sample size can be more representative of the population, 
limiting the influence of outliers or extreme observations.  For this project, the 100 AI charts 
encompassed the total number of AI that had undergone CABG at Sanford Health Fargo for the 
years 2008-2013.  A 1:1 match of post-CABG surgery patients was completed using the non-AI 
population for a representation of the total population involved in the previous study by Dyke et 
al. (2013), the difference in sample 100 vs 104 was two patients initially placed in the AI patient 
data did not meet the criteria and were moved to the non-AI group.    
 A third limitation of this practice improvement project may be multifactorial because 
providers at Sanford Health Fargo are provided discharge order sets within the EMR that meet 
the 2011 ACCF/AHA Guideline for patients following CABG surgery.  However, this guideline 
has not been followed in a majority of cases for both AI and non-AI patients concerning the use 
of guideline-directed medical therapy.  Despite algorithm-driven protocols set through the EMR, 
both AI and non-AI patients are not prescribed medications proven to decrease morbidity and 
mortality at time of discharge or in the immediate postoperative period.  Additionally, Sanford 
Health Fargo does not have guideline in place for cardiovascular surgeons that provided clear 
direction for scheduling post-CABG patients return outpatient appointments.  The importance of 
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optimal medical therapy and improved outpatient care remains necessary for positive outcomes 
not only in AIs, but also in all patients.  
The fourth limitation was the inability to gain access and approval through IHS to view 
medical records for continued medication therapy and return outpatient appointments with their 
primary care provider.  The restriction to IHS patient records limits the ability to conduct 
practice improvement projects that study if AI patients received follow-up care and if the 
provider followed current 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft 
Surgery when providing services.  Additionally, the restriction limits the access to care along 
with the level of care provided which may or may not lead to increased mortality in AI patient’s 
post-CABG.   
The final limitation was the inability to access data electronically through a query.  Data 
collection by human investigators can be the subject of errors.  With the use of an electronic data 
query, errors in data collection are minimized.  In addition, electronic data collection would have 
allowed for increased matching of patient variables including smoking, diabetes, and lung 
disease.  The increase in variables will reduce the potential for the occurrence and effect of 
confounding factors.   
Recommendations 
 Overall, several areas for improvement in care were identified in this project.  A logical 
recommendation for collaboration would be to partner with the IHS facilities in the region.  A 
collaborative relationship with IHS healthcare providers significantly affects the health of AIs.  
This collaboration would open the door for future projects, which can positively impact future 
generations.  Additionally, the collaboration could be a building block to a much larger and more 
beneficial partnership between health care providers and IHS, to look for ways to improve 
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outpatient care and the management of comorbid conditions that have been proven to 
significantly increase mortality rates.  With greater ease of access, patients could benefit from 
specialty providers such as cardiology, endocrinology, and nephrology while building a trusting 
relationship between the AI people and western medicine providers.   
 Secondly, there needs to be implementation of a CABG patient discharge algorithm 
(appendix D) to guide providers in the management of these patients to ensure better access to 
needed medical follow-up and available programs necessary to reduce the cardiovascular risk 
factors in CABG patients.  The algorithm guides providers in the medical management of 
patients to optimize medical therapies essential in high-risk patients using the current 2011 
ACCF/AHA guideline.  Additionally, the algorithm includes long-term guideline medical 
therapy for secondary prevention of coronary artery disease, utilization of cardiac rehabilitation 
programs, smoking cessation, management of comorbid conditions including diabetes mellitus, 
hypertension, and obesity.  Hillis et al.’s 2011 ACCF/AHA Guideline for Coronary Artery 
Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American 
Heart Association Task Force on Practice Guideline continues to be the gold standard that this 
project was focused on achieving.  Kulik et al. (2015) reported the importance for healthcare 
providers to implement these recommendations in appropriate CABG surgery patients as well as 
the importance of healthcare systems to support this implementation to maximize the benefit to 
the patient.  The current guideline recommendations include: 
1. Antiplatelet Therapy: Aspirin 81-325 mg should be administered preoperatively and 
within 6 hours after CABG.  It should be continued indefinitely. 
2. Lipid Management: Unless contraindicated, all CABG patients should receive statin 
therapy, starting preoperatively and restarted early after surgery. 
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3. Beta-Blocker Therapy: All CABG patients should be prescribed perioperative Beta-
blockers ideally starting before surgery.  CABG patients with a history of MI or LV 
dysfunction should be prescribed beta-blocker therapy unless contraindicated.  
4. Hypertension Management:  
a. Beta-blockers should be administered as soon as possible after CABG to reduce 
postoperative atrial fibrillation, and facilitate blood pressure control.  
b. ACE inhibitor therapy should be administered after CABG for patients with 
recent MI’s, LV dysfunction, diabetes mellitus, and chronic kidney disease, with 
careful consideration of renal function.  Routine ACE inhibitor therapy is not 
recommended early after CABG among patients do not have a history of   recent 
MI’s, LV dysfunction, diabetes mellitus, and chronic kidney disease because of 
the risk of more harm than benefit. 
c. It is reasonable to add calcium channel blocker or a diuretic agent as an additional 
therapeutic choice if not well controlled (Hillis et al. 2011). 
A third recommendation following this practice improvement project would be to 
develop a standardized order set for the purpose of scheduling postoperative office visits.  
American Indian patients had a higher prevalence of comorbid conditions so aggressive 
management of diabetes and other co-morbidities, as well as smoking cessation, is needed to 
reduce morbidity and mortality.  The lack of directed medical follow-up, and access to 
appropriate care, may be contributing to the disparity and increasing the mortality in the AI 
population.  Based on the evidence, an algorithm (Appendix D) was developed in collaboration 
with cardiothoracic surgery at Sanford Health Fargo in order to better manage post CABG 
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patients ensuring better access to needed medical follow-up and available programs necessary to 
reduce the cardiovascular risk factors in CABG patients. 
The current practice for most cardiothoracic surgeons is to schedule office visits for post-
CABG patients between two and four weeks post discharge.  They request patients be seen by 
the cardiology at an interval of six to eight weeks following discharge and post-CABG patients 
are told to see their PCP in one week.  The recommendation of this project is to revisit with the 
cardiothoracic surgeon at frequent intervals up to the one-year mark post discharge.  That would 
equate to approximately five visits the first year (2 weeks, 1 month, 3 months, 6 months, and 1 
year). Post-CABG patients need to be scheduled with cardiology physicians at regular intervals 
similar to cardiothoracic surgeon.  It is recommended that the patients be seen four times the first 
year (1, 3, 6 months and at 1 year), and then at least yearly.  Post-CABG patient visits should be 
scheduled regularly as needed with by the PCP’s of their choice.  It was recommended these 
follow-up appointments be scheduled within the first week following discharge, then at a 
minimum of every three months for the first year.  However, post-CABG patients with high 
incidents of modifiable risk factors should be seen at more frequent intervals (1 week, 3 week, 2 
months, 3 months, 6 months, and 1 year).  The need for follow-up with the patient’s PCP is vital 
to the overall outcome and reduction of comorbid conditions.  
The need to ensure post-CABG patients have an established PCP or a PCP prior to 
discharge is imperative to positive outcomes.  Kulik et al. (2015) reported for patients who have 
undergone CABG, when secondary prevention goals are not met at one year, the incidence of 
adverse cardiovascular events increase, regardless of the number of risk factors present.  
Allowing the patient to establish care in the community helps to minimize the barriers that may 
exist in the adoption of preventative therapies.  When looking at the SEM, we must empower the 
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individual and the family in order to make change.  The SEM is individual focused and if we can 
help create personal change, and change within an organization, the situation encourages the 
community to adapt through prevention programs such as cardiac rehabilitation, and smoking 
cessation.  
Implications for Practice 
 This practice improvement project provides insight into the use of the current EBP 
guideline for AI patient’s post-CABG surgery and post-operative follow-up care.  American 
Indians continue to be at high risk for cardiovascular disease and the risk factors associated with 
the disease.  To maximize patient benefit, efforts are needed in both secondary prevention and 
tertiary care, as primary prevention efforts at this point have been unsuccessful.  The need for 
collaboration between multiple disciplines across a wide spectrum of practice areas can prove to 
be problematic.  The CABG Patient Discharge Algorithm (appendix D) that was developed for 
this project establishes a form of communication between the cardiothoracic surgeon, cardiology, 
and the PCP.  This project is important because it raises awareness regarding the known 
disparities in AI health care, and provides an algorithm for providers to ensure all avenues of 
care have been addressed and secondary measures of health prevention are implemented.   
 This project can have its greatest effects on the AI population if a strong partnership 
between Sanford Health and Indian Health Services was implemented so there were outreach 
medical visits to IHS along with increased communication between cardiothoracic surgeons, 
cardiologists, and PCP’s.  This partnership could lead to changes in current practice and provide 
greater access to specialized medical providers to reduce disparities in this population.  The 
importance in using current evidenced-based guideline has been well documented.  The 
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significance of these guideline in the treatment of all patients with a history of CAD, regardless 
of race is to reduce the overall morbidly and mortality associated with coronary artery disease.   
The results of this project were disseminated to cardiothoracic surgeons and other 
healthcare professionals at Sanford Health Fargo.  Additional plans to disseminate the findings of 
this project will be at NDSU’s third annual DNP and master’s poster presentation, also at the 
2015 American Indigenous Research Conference in Pablo, Montana October 2015, as well as 
Encompassing American Indian Culture into Healthcare Conference, Fargo, North Dakota May 
2015.  Dissemination will also be accomplished by collaborating with Dr. Dyke in the writing 
and publishing a manuscript as well as planning future projects regarding AI patients and 
cardiovascular disease to incorporate current findings in upcoming studies.      
Healthcare providers working in a rural or in primary care settings are trusted with caring 
for individuals across the lifespan of different racial and ethnic backgrounds.  This project was 
designed to provide up to date guideline directed medical therapies in attempt to educate 
providers as well as the community to decrease the morbidity related to cardiovascular disease.  
This project enables providers to be leaders in healthcare policy as well as to educate the 
individual, family, the community and the organization.    
Implications for Future Practice Improvement Projects 
The need for continued study of the current problem is recommended.  If interested 
graduate students and researchers continue this project, one recommendation is to establish a 
partnership with IHS and complete the IHS IRB packet to gain access and approval for the 
studies.  This approval would need to be established early in the design process to thoroughly 
investigate follow-up medical care via chart audit or other appropriate methodologies.  This 
valuable partnership would enhance providers’ ability to provide education and care of AIs 
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following CABG and important secondary preventative measures.  The result of this project has 
set the groundwork for future studies in the reduction of mortality in AIs from coronary artery 
disease.  Dr. Dyke, Cardiothoracic surgeon at Sanford Health, reviewed this project. The results 
are promising, with strong potential to affect the care of AI patient.  Future studies are being 
considered and are in the planning stages.  
Additionally, future research could include collaborating with traditional community-
based healers and practitioners; this may be an important link to the outpatient care setting to 
ensure optimal care and improve mortality after surgery.  Providing care in the community may 
require collaboration with a cultural liaison that is well respected in the community.  This 
individual would assist in the education and teaching of community members, patients, and 
elders.  The use of a well-respected community liaison or traditional healer gives validation to 
the teaching as well as builds rapport and a trusting relationship.  Recognition of these issues 
presents an opportunity for continued improvement of care of the cardiac surgical patient both in 
the tertiary care setting and in the AI community.  
Application to Other DNP Roles 
The health disparities among American Indians, and other ethnic minorities, have been 
recognized and well documented.  The results of this project allow nurse practitioners and other 
providers to serve as leaders in the implementation of current evidenced based practice guideline 
in reducing mortality related to cardiovascular disease in all populations.  Nurse practitioners as 
well as other providers need to remain updated on current EBP guideline to ensure the best 
outcomes all patient populations.  
The role of the nurse practitioner to implement policy change within an organization is 
paramount to the successful of this project.  Nurse practitioners working in a rural setting are 
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typically caring for a vast number of patients and can have the most impact in follow-up care of 
patient’s post-CABG surgery.  The ability to educate patients on secondary prevention of 
disease, while using EPB guideline in the treatment of the disease will be beneficial.  The nurse 
practitioner may also be able to influence the community through educational classes, health 
workshops, and collaboration with community leaders as well as other health care professionals.  
Ultimately, nurse practitioners have the ability and the responsibility to provide high quality 
competent care aimed at decreasing the burden of coronary artery disease experienced in the 
American Indian population.      
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APPENDIX A. 2011 ACCF/AHA GUIDELINE FOR CORONARY ARTERY BYPASS 
SURGERY 
Perioperative Beta-blockers: Recommendations 
Class I 
 1- Beta-blockers should be administered for at least 24 hours before CABG to all patients 
without contraindications to reduce the incidence or clinical sequelae of postoperative 
AF. (Level of Evidence: B) 
 2- Beta-blockers should be reinstituted as soon as possible after CABG in all patients 
without contraindications to reduce the incidence or clinical sequelae of AF. (Level of 
Evidence: B) 
 3- Beta-blockers should be prescribed to all CABG patients without contraindications at 
the time of hospital discharge. (Level of Evidence: C) 
Class IIa 
 1- Preoperative use of beta-blockers in patients without contraindications, particularly in 
those with an LVEF greater than 30%, can be effective in reducing the risk of in-hospital 
mortality.  (Level of Evidence: B) 
 2- Beta-blockers can be effective in reducing the incidence of perioperative myocardial 
ischemia. (Level of Evidence: B) 
 3- Intravenous administration of beta-blockers in clinically stable patients unable to take 
oral medications is reasonable in the early postoperative period. (Level of Evidence: B) 
Class IIb 
 1- The effectiveness of preoperative beta-blockers in reducing in-hospital mortality rate 
in patients with LVEF less than 30% is uncertain. (Level of Evidence: B) 
ACE Inhibitors/ARBs: Recommendations 
Class I 
 1- ACE inhibitors and ARBs given before CABG should be reinstituted postoperatively 
once the patient is stable, unless contraindicated. (Level of Evidence: B) 
 2- ACE inhibitors or ARBs should be initiated postoperatively and continued indefinitely 
in CABG patients who were not receiving them preoperatively, who are stable, and who 
have an LVEF less than or equal to 40%, hypertension, diabetes mellitus, or CKD, unless 
contraindicated. (Level of Evidence: A) 
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Class IIa 
 1- It is reasonable to initiate ACE inhibitors or ARBs postoperatively and to continue 
them indefinitely in all CABG patients who were not receiving them preoperatively and 
are considered to be at low risk (i.e., those with a normal LVEF in whom cardiovascular 
risk factors are well controlled), unless contraindicated. (Level of Evidence: B) 
Class IIb 
 1- The safety of the preoperative administration of ACE inhibitors or ARBs in patients on 
chronic therapy is uncertain.  Level of Evidence: B) 
 2- The safety of initiating ACE inhibitors or ARBs before hospital discharge is not well 
established. (Level of Evidence: B) 
Postoperative Antiplatelet Therapy: Recommendations 
Class I 
 If aspirin (100 mg to 325 mg daily) was not initiated preoperatively, it should be initiated 
within 6 hours postoperatively and then continued indefinitely to reduce the occurrence 
of SVG closure and adverse cardiovascular events (Level of Evidence: A) 
Class IIa 
 For patients undergoing CABG, clopidogrel 75 mg daily is a reasonable alternative in 
patients who are intolerant of or allergic to aspirin. (Level of Evidence: C) 
Management of Hyperlipidemia: Recommendations 
Class I 
 1- All patients undergoing CABG should receive statin therapy, unless contraindicated. 
(Level of Evidence: A) 
 2- In patients undergoing CABG, an adequate dose of statin should be used to reduce 
LDL cholesterol to less than 100 mg/dL and to achieve at least a 30% lowering of LDL 
cholesterol (Level of Evidence: C) 
Class IIa 
 1- In patients undergoing CABG, it is reasonable to treat with statin therapy to lower the 
LDL cholesterol to less than 70 mg/dL in very high-risk⁎ patients.  (Level of Evidence: 
C) 
⁎ ⁎Presence of established cardiovascular disease plus 1) multiple major risk factors 
(especially diabetes), 2) severe and poorly controlled risk factors (especially continued 
cigarette smoking), 3) multiple risk factors of the metabolic syndrome (especially high 
 62 
 
triglycerides ≥200 mg/dL plus non–high-density lipoprotein cholesterol ≥130 mg/dL with 
low high-density lipoprotein cholesterol [<40 mg/dL]), and 4) acute coronary 
syndromes. 
 2- For patients undergoing urgent or emergency CABG who are not taking a statin, it is 
reasonable to initiate high-dose statin therapy immediately.  (Level of Evidence: C) 
Class III: Harm 
 1- Discontinuation of statin or other dyslipidemic therapy is not recommended before or 
after CABG in patients without adverse reactions to therapy. (Level of Evidence: B) 
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APPENDIX B. RETROSPECTIVE CHART AUDIT TOOL 
Retrospective Chart Audit Tool 
Date Collected ____/____/____ 
Random # ___________-______   Surgical Provider: ________________ 
Insurance: 
  ____IHS 
  _____ Commercial Insurance 
Medication Allergies:    Environmental / Latex Allergies: 
1.      1. 
2.      2. 
3.      3.  
4.      4.  
5.      5. 
Demographics: 
Age: _____ 
Gender: M / F  
Race/Ethnicity:  AI / Non-AI 
City:____________ State: _____ 
Body Mass Index: ______ 
Underweight (<18.5)  Normal (18.5-24.9) 
Overweight (25.0-29.9) Obese I (30.0-34.9 
Obese II ( 35.0-39.9)  Morbid Obesity (40.0+) 
Diabetes: Y / N 
Diet Control 
Oral Control 
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Insulin Control 
Hypertension: Y / N 
Current Smoker Y / N 
Chronic Lung Disease:  
Mild 
Moderate 
Severe 
Pre-Op CHF: Y / N 
PVD: Y / N 
CVD: Y / N 
Hx CVA: Y / N 
Dialysis Dependent: Y / N 
Creatinine (mg/dL): _____ 
Immunosuppressed: Y / N 
Previous CABG: Y / N 
Status: 
Elective       Urgent 
Emergent  Emergent Salvage 
Presentation: 
No Symptoms      Unlikely to be Ischemia 
Stable Angina      Unstable angina 
Non-STEMI          STEMI 
Hx of MI                   
<7 Days Prior 
8-21 Days Prior 
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 >21 Days Prior 
Cardiogenic Shock: Y / N 
Arrhythmia: Y / N 
Resuscitation: Y / N 
Left main disease (>50%): Y / N 
Ejection Fraction (%): ______ 
ADP Inhibitors: Y / N 
Admission Date ____/____/____  Follow-up provider and appointment dates: 
Surgery Date     ____/____/____    PCP _________________      _____/_____/_____ 
Discharge Date ____/____/____     Cardiology ____________    _____/_____/_____ 
Discharge Vitals: BP _____/____, HR_____  CV Surgery ____________   _____/_____/_____ 
Discharge Medications:    Follow-up medication changes 
Y / N Beta-blocker -Dose_______   1. 
Y /N ACE-Inhibitor/ARB -Dose _______  2. 
Y / N Lipid-lowering agent- Dose ______  3. 
Y / N Aspirin – Dose _______   4. 
 
Notes:    
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APPENDIX C. INSTITUTIONAL REVIEW BOARDAPPROVAL 
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APPENDIX D. CABG PATIENT DISCHARGE ALGORITHM  
 
Patient Discharged
Is Patient a Sanford 
Patient
Is Patient from IHS
Is patient from other
No
No
Follow up 
Appointments 
made with CV 
surgery
Follow up 
Appointments 
made with 
Cardiology
Follow up 
Appointment 
made with PCP
 Provider
 Date
 Time
 Has it been 
confirmed
 Provider
 Date 
 Time
 Has it been 
confirmed
 Provider
 Date 
 Time
 Has it been 
confirmed
Yes
At Sanford Health
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
At Sanford Health
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
Complete
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
 Provider
 Where
 Date
 Time
 Has it been 
confirmed
At Sanford Health
Yes
Yes
Complete
Complete
Complete
Complete
Complete
AtvSanford Health
At Sanford Health
Patient Preference
Patient Preference
Patient Preference
Patient preference
Discharge 
Medications
Aspirin
Therapy
Statin 
Therapy
Beta 
Blocker
ACEi/ARB
 Drug
 Dose
 Frequency
Rational
Consider EBP
 Drug
 Dose
 Frequency
Rational
Consider EBP
 Drug
 Dose
 Frequency
Rational
Consider EBP
 Drug
 Dose
 Frequency
Rational
Consider EBP
NO
No
No
No
Yes
Yes
Yes
Yes
Secondary 
Prevention
Cardiac 
Rehabilitation
YES
NO
Smoking 
Cessation 
Education 
complete
YES
NO
Hypertension
YES
NO
Who is managing
DM
YES
NO
Referral to 
Endocrine
Discharge CABG patient 
EBP algorithm 
Obesity
BMI
Refer to 
dietary
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APPENDIX F. EXECUTIVE SUMMARY 
Background 
The burden of cardiovascular disease is rising in American Indians (AI).  According to 
the Centers for Disease Control and Prevention (CDC, 2011), among racial/ethnic populations, 
coronary artery disease (CAD) prevalence was greatest among American Indians at 11.6%.  
American Indian’s have also been reported to have greater risk factors, prevalence, and mortality 
rates for cardiovascular disease (CVD) compared to other races (Eschiti, 2005; Veazie et al. 
2014), including diabetes mellitus, obesity, hypertension, and tobacco use (Kurian & Cardarelli, 
2007; Roger et al., 2012).  
Increased risk factors, not surprisingly, results in twice the numbers of cardiovascular 
events as compared to the non- AI population, in turn leading to higher mortality rates in this 
population.  With respect to AIs undergoing surgical revascularization with coronary artery 
bypass grafting (CABG), mortality rates are reported to be higher than the general population 
and other ethnic groups (Nallamothu et al., 2001).  Understanding this disparity and identifying 
potential causes is needed to reduce health care disparities in AI following surgical coronary 
revascularization.  
Project Summary 
Based on the need to reduce mortality rates in AI following surgical coronary artery 
revascularization, a retrospective study of patients who had underwent coronary artery 
revascularization at Sanford Health, Fargo, North Dakota from the years 2008-2013.  This 
retrospective study examined the medical records of 100 AI patients and 100 medical records of 
non-AI patients.  Data collected included patient demographics, allergies, discharge medications, 
and follow-up care.  This data was quantified to identify potential deficiencies is practice in 
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hopes of developing strategies for improving care.  Current ACCF/AHA evidenced based 
guideline (Hillis et al., 2011) for management of patients following CABG was used as a basis 
for guideline-directed medical therapy on reducing the morbidity and mortality of patients 
following CABG. 
Results 
The data confirm that AIs are a high-risk population with significant risk factors for poor 
outcomes (diabetes, active tobacco use, and acute presentation) following CABG.  However, 
data collected regarding the EBP for guideline-directed medical therapy to include prescribing of 
beta-blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor 
blockers (ARB’s), high intensity statin therapy, and antiplatelet (aspirin) therapy (Table 2) at 
discharge was not significant to definitively pinpoint the cause of increased mortality in the AI 
populations. 
The data collected supports the assumptions that adherence to and reduced access to care 
may potentially contribute to an increase in mortality in the AI population following CABG 
surgery.  Data collected regarding medical follow-up (Table 3) represent the comparison of AI 
and non-AIs.  This table clearly depicts a deficiency in follow-up care for AIs with a PCP and 
although not statistically significant, follow-up with cardiology was consistently below that of 
non-AI.  The reason for this is likely to be multifactorial to include reduced access to health care, 
economical, and adherence to prescribed treatment plans.  Overall, the results indicated a need 
for algorithm driven protocols, and the need for continued, frequent follow-up care is essential.  
Recommendations  
The results of the current project lead to several recommendations.  The first would be to 
collaborate with the IHS facilities in the region.  Healthcare providers working in IHS have an 
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opportunity to significantly impact the health of AIs.  The collaboration could be a building 
block to a much larger and more beneficial partnership between health care providers and IHS, to 
look for ways to improve outpatient care and the management of comorbid conditions that have 
been proven to significantly increase mortality rates. 
Secondly requires the implementation of CABG patient discharge algorithm (appendix E) 
to guide providers in the management of post CABG patients and to ensure better access to 
needed medical follow-up and available programs necessary to reduce the cardiovascular risk 
factors in CABG patients.  The algorithm guides providers in the medical management of 
patients to optimize medical therapies essential in high-risk patients using the current EBP 
guideline.   
Lastly, will be to develop a standardized order set for the purpose of scheduling 
postoperative office visits.  AI patents had a higher prevalence of comorbid conditions and long-
term, aggressive management of diabetes and other co-morbidities, as well as smoking cessation, 
is needed to reduce morbidity and mortality.  The lack of directed medical follow-up, and access 
to appropriate care, individuals may be contributing to the disparity and increasing the mortality 
in the AI population. 
